Details for New Drug Application (NDA): 207139
✉ Email this page to a colleague
NDA 207139 describes PAROXETINE MESYLATE, which is a drug marketed by Actavis Labs Fl Inc and Prinston Inc and is included in two NDAs. It is available from one supplier. Additional details are available on the PAROXETINE MESYLATE profile page.
The generic ingredient in PAROXETINE MESYLATE is paroxetine mesylate. There are thirty drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the paroxetine mesylate profile page.
The generic ingredient in PAROXETINE MESYLATE is paroxetine mesylate. There are thirty drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the paroxetine mesylate profile page.
Summary for 207139
| Tradename: | PAROXETINE MESYLATE |
| Applicant: | Actavis Labs Fl Inc |
| Ingredient: | paroxetine mesylate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 7.5MG BASE | ||||
| Approval Date: | Jun 20, 2017 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
